how to get retatrutide prescription UK Guide: Key Facts on the New Weight-Loss Drug How to Get a Retatrutide

Retatrutide (also referred to by its development code LY3437943) is an investigational, once-weekly injection developed by Eli Lilly and Company

Some employer plans still exclude weight loss medications entirely

A medical provider will review your history and help determine if injections are safe for you

Patients on retatrutide frequently describe feeling satiated with smaller amounts of food, contributing to their reduced caloric intake

Reta: Appetite Regulation By stimulating GLP-1 and GIP receptors, Reta appears to signal satiety centers in the hypothalamus, potentially reducing food intake in preclinical animal models

Expected outcome: Some metabolic support during transition, though weight regain is common regardless of supplementation after stopping GLP-1 medications